The Impact of COVID-19 Pandemic on Tuberculosis Patient Treatment Adherence
Coronavirus disease 2019 (COVID-19) pandemic caused a lack of attention to treatment of tuberculosis (TB). TB patients who do not adhere to treatment during a pandemic can cause various health problems in various countries. COVID-19 pandemic adversely affects TB patients such as increasing psychological stress, triggering non-adherence to treatment, affecting quality of life, and even increasing the number of deaths of TB patients. The increasing number of deaths and decreasing success of TB treatment during the pandemic are serious problems that must be addressed immediately. Various efforts were made to overcome the barriers for TB treatment during pandemics. Health workers can provide health education and rehabilitation programs in another media such as tele-health. Digital media can provide health information about TB, improve medication adherence, emphasize the benefits of medication adherence, and motivate patients to undergo treatment.
Kant S, Tyagi R. The Impact of COVID-19 on Tuberculosis: Challenges and Opportunities. Ther Adv Infect Dis 2021; 8: 1–7.
Duarte R, Aguiar A, Pinto M, et al. Different Disease, Same Challenges: Social Determinants of Tuberculosis and COVID-19. Pulmonology 2021; 27: 338–344.
Fei H, Yinyin X, Hui C, et al. The Lancet Regional Health - Western Pacific The Impact of the COVID-19 Epidemic on Tuberculosis Control in China. Lancet Reg Heal - West Pacific 2020; 3: 100032.
World Health Organization. Tuberculosis and COVID-19: Considerations for Tuberculosis Care. World Heal Organ 2020; 1–11.
Irfani TH, Siburian R, Nabila R, et al. Tuberculosis and Coronavirus Disease 2019 (COVID-19) From a Clinical Perspective: A Systematic Review. Medeni Med J 2020; 35: 338–343.
Tovar M, Joaquín Sanz AA, Moreno Y. A Significant Increase in Tuberculosis Diagnosis is Required to Mitigate the Impact of COVID-19 on Its Future Burden. Medrxiv.
Malik AA, Safdar N, Chandir S, et al. Tuberculosis Control and Care in the Era of COVID-19. Health Policy Plan 2020; 35: 1130–1132.
Yoeli E, Rathauser J, Bhanot SP, et al. Digital Health Support in Treatment for Tuberculosis. N Engl J Med 2019; 381: 986–987.
Gupta A, Singla R, Caminero JA, et al. Impact of COVID-19 on Tuberculosis Services in India. Int J Tuberc Lung Dis 2020; 24: 637–639.
Putra KWR, Toonsiri C. Factors Related to the Successful Treatment of Tuberculosis: A Literature Review. Belitung Nurs J 2019; 5: 136–146.
World Health Organization. Tuberculosis. WHO.
Silva DR, Mello FC de Q, D’ambrosio L, et al. Tuberculosis and COVID-19, the New Cursed Duet: What Differs between Brazil and Europe? J Bras Pneumol 2021; 47: 1–8.
Visca D, Ong CWM, Tiberi S, et al. Tuberculosis and COVID-19 Interaction: A Review of Biological, Clinical and Public Health Effects. Pulmonology 2021; 27: 151–165.
World Health Organization. Coronavirus.
Syafa’ah I. Non-Invasive Ventilation in COVID-19 Related Respiratory Failure. J Respirasi 2021; 7: 139.
World Health Organization. Coronavirus Disease (COVID-19): Tuberculosis. WHO.
R. G. G, D’souza MJ, . A. Adherence to Anti-Tuberculosis Treatment among Patients in Urban Field Practice Area of Medical College, Davangere, Karnataka: A Qualitative Study. Int J Community Med Public Heal 2019; 6: 2555.
Gebreweld FH, Kifle MM, Gebremicheal FE, et al. Factors Influencing Adherence to Tuberculosis Treatment in Asmara, Eritrea: A Qualitative Study. J Heal Popul Nutr 2018; 37: 1–9.
Kretchy IA, Asiedu-Danso M, Kretchy JP. Medication Management and Adherence during the COVID-19 Pandemic: Perspectives and Experiences from Low- and Middle-Income Countries. Res Soc Adm Pharm 2021; 17: 2023–2026.
Fekadu G, Bekele F, Tolossa T, et al. Impact of COVID-19 Pandemic on Chronic Diseases Care Follow-Up and Current Perspectives in Low Resource Settings: A Narrative Review. Int J Physiol Pathophysiol Pharmacol 2021; 13: 86–93.
Jain VK, Iyengar KP, Samy DA, et al. Tuberculosis in the Era of COVID-19 in India. Diabetes Metab Syndr Clin Res Rev 2020; 14: 1439–1443.
Sarinoglu RC, Sili U, Eryuksel E, et al. Tuberculosis and COVID-19: An Overlapping Situation during Pandemic. J Infect Dev Ctries 2020; 14: 721–725.
Kaur R, Singh T, Singh SM, et al. Effect of Psychiatric Co-Morbidity on Adherence to Anti Tubercular Treatment: A Cross Sectional Study from North India. Int J Community Med Public Heal 2021; 8: 1325.
Visca D, Tiberi S, Pontali E, et al. Tuberculosis in the Time of COVID-19: Quality of Life and Digital Innovation. Eur Respir J; 56. Epub ahead of print 2020. DOI: 10.1183/13993003.01998-2020.
Febi AR, Manu MK, Mohapatra AK, et al. Psychological Stress and Health-Related Quality of Life among Tuberculosis Patients: A Prospective Cohort Study. ERJ Open Res 2021; 7: 00251–02021.
Putu N, Purnama W, Kurnia A, et al. Comparison of Stress Level and Coping Strategy between Therapeutic Phases in Newly Diagnosed Tuberculosis. 9. Epub ahead of print 2020. DOI: 10.11591/ijphs.v9i2.20410.
Fuadiati LL, Dewi EI, Hadi E. Hubungan Mekanisme Koping dengan Stres Pasien TB Paru di Rumah Sakit Paru Jember. Pustaka Kesehat 2019; 7: 71.
Maharjan B, Gopali RS, Ishikawa N, et al. Psychosocial and Nutritional Counselling Intervention for Tuberculosis Patient Improves Patient’s Stress and Treatment Adherence: A Case Study from Nepal. Int J Heal Syst Implement Res 2018; 2: 35–40.
Khairnar DR, Markad S. Socio-Psychological Effects on Tuberculosis Patients from Maharashtra, India. J Assoc Physicians India 2021; 69: 64–68.
Putra MM, Sari NPWP. Model Theory of Planned Behavior to Improve Adherence to Treatment and the Quality of Life in Tuberculosis Patients. J Ners 2020; 15: 167.
Copyright (c) 2022 Natalia Christin Tiara Revita, Tintin Sukartini, Makhfudli, Joel Rey Ugsang Acob, Hasanudin, Handira Nadhifatul Aini
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
1. The journal allows the author to hold the copyright of the article without restrictions.
2. The journal allows the author(s) to retain publishing rights without restrictions.
3. The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution Share-Alike (CC BY-SA).
4. The Creative Commons Attribution Share-Alike (CC BY-SA) license allows re-distribution and re-use of a licensed work on the conditions that the creator is appropriately credited and that any derivative work is made available under “the same, similar or a compatible license”. Other than the conditions mentioned above, the editorial board is not responsible for copyright violation.